PTPN11 and deep vein thrombosis: Additionally, SHP2 blockade treated with the tumor inhibitor SHP099 in lung metastatic tumor mice was discovered not only to suppress tumor metastasis but also to reduce thrombi count and was further identified in a DVT mouse model to dose‐dependently decrease intrathrombus collagen, possessing a potential thrombolytic effect at its high dosage.